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Abstract
The major outer sheath protein (Msp) of Treponema denticola perturbs actin dynamics in fibroblasts by inducing actin
reorganization, including subcortical actin filament assembly, leading to defective calcium flux, diminished integrin
engagement of collagen, and retarded cell migration. Yet, its mechanisms of action are unknown. We challenged Rat-2
fibroblasts with enriched native Msp. Msp activated the small GTPases Rac1, RhoA and Ras, but not Cdc42, yet only Rac1
localized to areas of actin rearrangement. We used Rac1 dominant negative transfection and chemical inhibition of
phosphatidylinositol-3 kinase (PI3K) to show that even though Rac1 activation was PI3K-dependent, neither was required
for Msp-induced actin rearrangement. Actin free barbed end formation (FBE) by Msp was also PI3K-independent.
Immunoblotting experiments showed that gelsolin and CapZ were released from actin filaments, whereas cofilin remained
in an inactive state. Msp induced phosphatidylinositol (4,5)-bisphosphate (PIP2) formation through activation of a
phosphoinositide 3-phosphatase and its recruitment to areas of actin assembly at the plasma membrane. Using a PIP2
binding peptide or lipid phosphatase inhibitor, PIP2 was shown to be required for Msp-mediated actin uncapping and FBE
formation. Evidently, Msp induces actin assembly in fibroblasts by production and recruitment of PIP2 and release of the
capping proteins CapZ and gelsolin from actin barbed ends.
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Introduction
Modulation of the host cytoskeleton and its related signalling
pathways is a common infection strategy of many bacterial
pathogens. Many species act extracellularly; others produce
secreted virulence factors that interact directly with host cell
cytoskeletal components or cytoskeletal regulatory proteins upon
injection. Some virulence factors modulate signal transduction
pathways, such as activating or de-activating small GTPases,
molecular switches that control many cellular functions, including
actin remodelling (for review see [1,2]). Treponema denticola is a
prominent oral spirochete associated with polymicrobial peri-
odontal infections and chronic periodontal disease progression
[3,4,5], and it is known to perturb the actin cytoskeleton of
fibroblasts, epithelial cells, and neutrophils.
The major outer sheath protein (Msp) of T. denticola is an
immunogenic surface antigen [6] which is also associated with
released membrane vesicles [7]. Msp displays structural and
functional similarity to cytotoxic membrane porins [8], and it is
able to bind extracellular matrix proteins [6,8,9]. Serum
antibodies of humans with periodontal disease recognize Msp,
confirming the interaction of this protein with immunogenic cells
in the periodontium [10]. T. denticola is highly motile due to its
flagella [11]; thus along with its innate proteolytic activity
[12,13,14], T. denticola is able to penetrate the epithelium and
interact directly with cells in periodontal connective tissues. Msp
perturbs actin dynamics in both fibroblasts and neutrophils,
leading to impaired cell migration and chemotaxis [15,16,17].
Msp also impairs calcium signalling and collagen binding in
fibroblasts, as well as causing cell rounding and shrinkage, most
likely due to Msp-induced subcortical actin assembly near the
plasma membrane [18,19]. The impact of bacterial proteins like
Msp on actin dynamics would be expected to perturb numerous
cellular functions that depend on cytoskeletal physiology.
Cell locomotion during inflammatory responses and wound
healing requires coordinated cycles of actin assembly and
disassembly at the plasma membrane. In fibroblasts, it is well
established that migration requires extension of a leading edge
lamellipodium along with the formation of adhesion complexes
and the coincident detachment of focal complexes in areas trailing
the leading edge [20]. Initiation of cell migration involves the
formation of actin free barbed ends (FBE), along with subsequent
filament elongation by the addition of actin monomers to push the
membrane outward and to sustain the leading edge. Thus there is
a dynamic ‘‘treadmilling’’ between the monomeric and filamen-
tous actin pools in the cell [21]. In this study, we concentrated on
mechanisms by which Msp could affect actin filament assembly in
fibroblasts.
Multiple actin binding and severing proteins regulate the
formation of FBEs and subsequent assembly of actin filaments.
Normally, FBEs are blocked by a capping protein, such as capZ or
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these proteins creates available FBEs. Nucleation of new actin
filaments and subsequent branching of actin networks often occur
by proteins of the Arp2/3 complex. Severing of formed actin
filaments by proteins, including gelsolin and cofilin, also regulates
actin reorganization [23,25].
Members of the Rho small GTPase family act as molecular
switches to control signal transduction pathways in eukaryotic
cells, and they are key regulators of the actin cytoskeleton [20,26].
Their activity varies by cycling between an inactive GDP-bound
and an active GTP-bound state [27]. Plasma membrane
phosphoinositides also play a key role in actin cytoskeleton
regulation. Membrane phosphatidyl (4,5)-bisphosphate (PIP2) acts
as a direct regulator of actin binding and capping proteins [28,29].
PIP2 is also converted to phosphatidyl (3,4,5)-trisphosphate (PIP3)
by the action of phsophoinositol-3 kinases (PI3K). PIP3 subse-
quently acts as a second messenger that regulates small GTPase
signalling cascades [30].
In this study, we first hypothesized that Rac1 played a key role
in Msp-induced actin rearrangement in fibroblasts. However,
though Rac1 was activated, we found subsequently in further
experiments that it was not required for actin rearrangement upon
fibroblast exposure to Msp. Instead, we describe a novel
mechanism that leads to actin FBE formation in fibroblasts: Msp
induces de novo actin filament assembly through the local
production and recruitment of PIP2 by phosphoinositide phos-
phatase activity and the removal of capping proteins from actin
filaments.
Results
Msp activates multiple small GTPases in fibroblasts
We used ELISA-based and pulldown assays to study the impact
of Msp on members of the Rho and Ras families of small
GTPases. Msp treatment of Rat-2 fibroblasts resulted in activation
of Rac1, RhoA and Ras in a time-dependent manner. Each of
these small GTPases was activated as early as 5 min following cell
exposure to Msp (Figure 1A–C). No significant activation of cdc42
was found (Figure 1D).
Rac1 localizes in actin-rich areas of Msp-treated
fibroblasts
Msp is known to induce de novo subcortical actin filament
assembly in fibroblasts [15,18,19], but its mechanisms of action are
relatively unknown. Since the small GTPases, Rac1 and Cdc42
are key regulators of actin remodelling [26] we sought to
determine their localization and their relationship to areas of
Msp-induced actin reorganization. By immunofluorescence mi-
croscopy of phalloidin-labelled cells, we confirmed our labora-
tory’s previous reports that Msp treatment resulted in the loss of
stress fibers near the centre of the cell along with the emergence of
actin filament-rich areas at the cell periphery. In control cells,
Rac1 showed a faint punctate cytoplasmic distribution. Following
Msp treatment, Rac1 redistributed to actin-rich areas near the
plasma membrane (Figure 2A, arrowheads). In contrast, RhoA
and Cdc42 showed more diffuse cytoplasmic distribution following
Msp treatment compared with control cells; neither was co-located
with actin filaments within actin rich-areas of the cytoplasm
(Figure 2B,C).
Msp-mediated Rac1 activation is PI3K-dependent
One of the major mechanisms of Rac1 activation involves PIP3
binding to guanine nucleotide exchange factors (GEFs) [30]. As
PI3K phosphorylates membrane lipids to produce lipid second
messengers, including PIP3, we asked whether inhibition of PI3K
would affect Msp-induced small GTPase activation. Pretreatment
of fibroblasts with the chemical PI3K inhibitor LY294002
prevented Rac1 activation by subsequent Msp treatment
(Figure 3A). This finding suggests that Msp increases PI3K activity
upstream of Rac1 activation.
Even though we found that Msp increased RhoA-GTP in
fibroblasts, RhoA activation evidently does not occur via the PI3K
pathway, as cells pretreated with LY294002 prior to Msp
stimulation showed RhoA-GTP activity similar to that of non-
LY294002-treated control cells (Figure 3B). Fibroblasts treated
with LY294002 prior to subsequent platelet-derived growth factor
(PDGF; positive control) stimulation, showed significantly de-
creased levels of the downstream PI3K effector Akt, confirming
inhibition of the PI3K pathway by this chemical inhibitor (data not
shown).
Msp does not activate the PI3K/ Akt signalling pathway
The downstream PI3K effector Akt, may function in actin
remodelling [31]. As we had evidence that Msp may activate
PI3K, we determined whether Msp acted through Akt to induce
actin remodelling. Immunoblotting analysis of cell lysates from a
time course of Msp treatment of fibroblasts showed no activation
of Akt, measured by phosphorylation at serine 473. Control
fibroblasts showed no detectable level of Akt phosphorylation
while cells stimulated with 50 mgm l
21 PDGF showed strong
activation (Figure 4A). Additionally, comparative immunoblotting
of fibroblast cytosol and membrane fractions revealed increased
association of Akt with the membrane following Msp treatment
(Figure 4B,C). Together these results suggest that Msp may result
in translocation of Akt to the plasma membrane, but not
subsequent Akt activation. Apparently, Msp does not activate
the PI3K / Akt arm of the signalling pathway.
Rac1 is not required for Msp-mediated actin
rearrangement
As Rac1, a known primary regulator of actin reorganization,
was located at the actin-rich areas of Msp-treated fibroblasts, we
sought to determine the role of this small GTPase in actin
remodelling. To inhibit Rac1 activity, we transfected cells with a
Rac1T17N dominant-negative (DN) construct. Rac1 inhibition in
transfected cells was confirmed by stimulation with EGF
(Figure 5A). Following Msp treatment of transfected cells, actin-
rich ruffles and a strong ring of subcortical actin were still observed
by Alexa-phalloidin fluorescence, similar to non-transfected cells
(Figure 5B). Evidently, Rac1 is not required for actin rearrange-
ment following cell exposure to Msp.
PI3K is not required for Msp-mediated FBE formation or
total actin rearrangement
Fibroblast treatment with Msp was shown previously to result in
increased formation of subcortical actin FBEs [15]. Although Rac1
was apparently not required for Msp-mediated actin rearrange-
ment in the present study, PI3K pathways are also known to
regulate actin formation. We used a fluorescent-labelled actin
monomer incorporation assay and observation of total F-actin
labelling to determine the effect of PI3K inhibition. Treatment of
cells with the PI3K inhibitor LY294002 prior to Msp resulted in
levels of FBE formation and monomer incorporation similar to
Msp treatment alone (Figure 6A). As well, when total F-actin
labelling using Alexa-phalloidin was examined; cells treated with
Msp alone or with LY294002 and Msp both showed comparably
strong subcortical actin fluorescence and cell rounding (Figure 6B).
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F-actin rearrangement are PI3K-independent.
Actin rearrangement is partially restored in a T. denticola
Msp mutant
To establish the role of Msp in whole bacteria on the fibroblast
actin cytoskeleton, we tested wildtype T. denticola 35405 and the
Msp mutant MHE in an immunofluorescence stress fiber assay.
Treatment of fibroblasts with wildtype T. denticola increased the
number of cells with altered stress fibers, similar to previous studies
[32,33], while the Msp mutant, MHE only partially altered
fibroblast stress fibers (Figure 7). This finding indicates that like
enriched Msp preparations, Msp in its native bacterial background
impacts the host cell actin cytoskeleton, as a Msp mutant strain
showed decreased stress fiber disassembly.
Msp-mediated FBE formation is due to actin uncapping
The mechanism by which Msp induces actin FBE formation is
unknown. FBE formation is regulated by interactions of multiple
actin binding proteins. The actin severing protein cofilin is able to
cleave pre-existing actin filaments, and thereby generate FBEs
when present in the active dephosphorylated form. However,
cofilin activity is blocked when phosphorylated at serine 3 [34].
Following Msp treatment, no dephosphorylation of cofilin was
observed in cell lysates, as compared with control epidermal
growth factor (EGF)-treated fibroblasts, which resulted in obvious
activation of cofilin (Figure 8).
The actin-binding protein gelsolin is able to sever existing
filaments as well as cap the newly formed FBEs [24] whereas
capping protein CapZ caps the actin barbed end directly [22]. We
used immunoblotting analysis to quantify the amount of gelsolin
and CapZ released from partially permeabilized cells following
Msp treatment. Cell exposure to Msp increased the release of both
gelsolin and CapZ from partially permeabilized fibroblasts over
time, compared with non-treated control cells (Figure 9). These
results suggest that FBE formation induced by Msp is due to the
increased removal of actin capping proteins gelsolin and CapZ.
We then sought a mechanism to account for this activity.
Msp induces PIP2 recruitment to actin-rich domains at
the plasma membrane and increases PIP2 levels
PIP2 is a well-characterized regulator of the actin cytoskeleton
that isable tointeract directlywith actin bindingproteinstoregulate
their function, including capping of FBEs [29]. To study the
dynamics of PIP2 following Msp treatment, we used the pleckstrin
homology (PH) domain of Phospholipase C (PLC) d1 fused to GFP
(PH-PLCd1-GFP) as a fluorescent probe [35]. Following exposure
of fibroblasts to Msp, areas of focal PLCd1-GFP fluorescence were
observed, due to recruitment of PIP2, compared to diffuse
cytoplasmic localization in control cells (Figure 10A). Co-localiza-
tion analysis revealed PLCd1-GFP in areas rich in F-actin and the
plasma membrane marker wheat germ agglutinin (WGA) (Fig. 10A,
Pearson coefficient analysis (control vs Msp): PLC/actin 0.463 6
0.037 vs 0.626 6 0.0261, PLC/ WGA 0.355 6 0.0405 vs 0.625 6
Figure 1. Activation of small GTPases following Msp exposure. Rat-2 fibroblasts were treated with Msp in a time course. At the indicated
times, cells were lysed and the level of active Rac1 (A), RhoA (B) or Cdc42 (C) were measured using the appropriate G-LISA. The amount of active Ras
(D) in cell lysates was measured using a Raf-RBD pulldown assay. Cells were treated with EGF or LPA as a positive control. Graphs represent the fold
change relative to non-treated cells (mean 6 SEM, *P,0.05, **P,0.01, ***P,0.001).
doi:10.1371/journal.pone.0023736.g001
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exposure, strong fluorescence was also observed along the plasma
membrane, similar to localization of the subcortical meshwork of
actin filaments (data not shown). To confirm our imaging results we
used a PI(4,5)P2mass ELISAtomeasure PIP2levels followingMsp
treatment.LipidextractsfromMsptreatedcellscontainedincreased
levels of PI (4,5) P2 compared to extracts from control cells
(Figure 10B). Together with these results we analyzed the
localization of the PH domain of Akt fused to GFP (PH-Akt-
GFP), which is able to bind to PI (3,4,5) P3 [35]. Following Msp
treatment, no significant increase in fluorescence for this probe at
the plasma membrane was detected, unlike in cells following PDGF
stimulation (Figure S1).
Changes in PIP2 levels in the cell can result either from the
activity of phosphatidylinositol kinases (PIPK) or phosphoinositide
phosphatases [36]. We used a modified malachite green assay in
combination with soluble PIP3 as a substrate to measure
phosphatase activity. Following Msp treatment, the amount of
free phosphate released from partially permeabilized cells
increased in a time-dependent manner (Figure 10C).
PIP2 is required for actin uncapping and actin FBE
formation
We used two approaches to confirm that PIP2 is linked to actin
uncapping following Msp treatment. Cells were pretreated with
the cell-permeable phosphoinositide-binding peptide PBP-10 or
the lipid phosphatase inhibitor bpV(pic), prior to Msp. Treatment
of fibroblasts with either of these compounds prevented Msp-
mediated uncapping, confirming the involvement of PIP2 in this
uncapping mechanism (Figure 11A,B, S2).
As this initial experiment showed that PIP2 is required for
removal of gelsolin and CapZ from actin ends, we also used this
approach to confirm a link between the uncapping proteins and
actin FBE formation. Cells treated with Msp showed strong
fluorescence along the cortical edge (Figure 11C, arrow) while cells
treated with PBP-10 prior to Msp treatment showed no
fluorescence at the cortical edge (Figure 11C, arrowheads). This
finding indicates indirectly that gelsolin and CapZ are required for
actin FBE formation. In the absence of PIP2, removal of these
proteins from actin ends does not occur and consequently FBEs
are not formed.
Discussion
Pathogenic bacteria are able to perturb the eukaryotic cell
cytoskeleton through signal transduction systems that initiate upon
Figure 2. Msp induces re-localization of Rac1 to actin-rich
areas. Immunofluorescence microscopy images of fibroblasts following
exposure to Msp. Rac1 (A, arrows) is localized to actin-rich areas
(A, arrowheads) at the cell periphery. Msp resulted in changed
distribution of both RhoA (B) and Cdc42 (C), however neither localized
to areas of remodelled actin. Alexa-phalloidin was used to label F-actin
while specific antibodies were used to label each small GTPase. Images
are representative of 3 experiments. Bar represents 25 mm.
doi:10.1371/journal.pone.0023736.g002
Figure 3. Msp mediated Rac1 activation is PI3K-dependent. Prior to Msp treatment for 15 min, fibroblasts were treated with nothing, vehicle
or the PI3K inhibitor LY294002 for 30 min. Activation of Rac1 and RhoA was measured in cell lysates using a G-LISA. Pretreatment with LY294002 was
able to inhibit Rac1 activation (A) but not RhoA activation (B) by Msp, compared to Msp treatment alone. Graphs are representative of 3 independent
experiments (mean 6 SEM, *P,0.05, **P,0.01).
doi:10.1371/journal.pone.0023736.g003
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interactions of either shed or secreted proteins that gain entry to
the cytoplasm. Previously, our laboratory reported that whole
bacteria, outer membrane preparations, as well as the native Msp
from T. denticola were able to induce actin reorganization in
fibroblasts, including a loss of stress fibers [15,19,33]. Msp also
induced the formation of new actin FBEs [15]. The resultant de
novo subcortical actin filament assembly was a crucial determinant
for two entirely novel downstream effects: 1) conformational
inhibition of store-operated calcium influx and 2) inside-out
modulation of the affinity of extracellular ligand engagement
[18,19]. In the current investigation, we traced in detail significant
pathways and mechanisms that may account for actin filament
assembly following Msp induction of FBEs. Our major findings
were that 1) Msp stimulates PIP2 production and its local
recruitment in fibroblasts, probably leading to the removal of
capping proteins from actin filaments to expose barbed ends, and
2) though Msp activates PI3K upstream of small GTPases, neither
Rac1 nor PI3K are required for Msp-induced actin rearrange-
ment.
A previous study by our group found that Msp inhibited Rac1
activation selectively in neutrophils, resulting in impaired polar-
ization and chemotaxis in response to a chemoattractant [16]. Yet,
by an identical method that analyzed bound GTP, we found that
Msp clearly activated Rac1 in a time-dependent manner in
fibroblasts, as early as 5 min following Msp treatment, suggesting a
role for Rac1 in early signalling events in these stromal cells. It is
possible that the difference in responses between these cell types
may derive from the expression of Rac2 as well as Rac1 by
neutrophils, whereas fibroblasts are known to express only Rac1
[37].
RhoA activation is normally associated with the assembly of
actin stress fibers and focal adhesions [38]. Yet, in our current
study, treatment with the native Msp complex resulted in the
activation of RhoA along with coincident loss of stress fibers.
Under some circumstances, Rho signalling may be uncoupled
from stress fiber formation in fibroblasts. Ras-transformed
fibroblasts lack actin stress fibers, yet also show high levels of
RhoA-GTP [39]. It has been determined that prolonged MAPK
signalling may also play a major role in stress fiber uncoupling at
the level of impairing the response to downstream Rho-kinase
function [39]. This led us to analyze the levels of Ras-GTP
expression in Msp-treated fibroblasts. Using affinity pulldown
assays, we observed increased activation of Ras initially at 5 min
following Msp exposure. As well, prolonged activation of the
MAPKs p38, ERK [40] and JNK (M.B. Visser, unpublished),
maximal between 15 to 30 min, was observed in Msp-treated
fibroblasts, suggesting that these mechanisms may be involved in
Figure 5. Rac1 is not required for Msp-mediated actin
rearrangement. (A) Immunoblot confirmation of Rac1 inhibition
following Rac1T17N-GFP transfection. Active Rac1 was measured by
pulldown assay following EGF stimulation. (B) Fibroblasts were
transiently transfected with a Rac1T17N-GFP construct for 24 h,
followed by Msp exposure for 60 min. Samples were fixed and stained
with Alexa-phalloidin to label total F-actin. Inhibition of Rac1 activity by
transfection was not able to impair subcortical actin remodelling by
Msp. Bar represents 10 mm.
doi:10.1371/journal.pone.0023736.g005
Figure 4. Msp results in Akt translocation but not activation. (A)
Msp treated fibroblasts were analyzed for Akt phosphorylation at serine
473 as a measure of activation. No activation of Akt following Msp
exposure was observed by immunoblotting. (B) Densitometry analysis
of Akt localization to membrane or cytosol fractions following Msp
treatment. Graph represents two immunoblotting experiments (mean
6 SEM, * P,0.05). (C) Representative immunoblots demonstrating
recruitment of Akt to the membrane following Msp treatment. PDGF
treatment of cells serves as a positive control for Akt phosphorylation in
panel A.
doi:10.1371/journal.pone.0023736.g004
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stress fibers.
The initial steps in cell migration involve formation of a leading
edge that is visible as actin-rich membrane protrusions or ruffles,
processes that require Rac1 and PI3K. In the early stages of Msp
treatment, Rac1 was recruited to the plasma membrane actin-rich
areas, some of which appear to be membrane ruffles. This is
similar to the actin filament pattern observed in cells expressing
activated Rac1 or by external growth factor stimulation [41]. The
major mechanism of small GTPase activation involves binding of
PIP3 to GEFs [30]. Using chemical inhibition studies, we
established that Msp activates the PI3K pathway, determined by
its requirement for activation of the indirect downstream effector,
Rac1. However, the well established PI3K downstream mediator
Akt was not activated by Msp. Our studies here suggest that Msp
was able to activate PI3K, which in turn would phosphorylate
membrane lipids to produce PIP3. PIP3 could then bind GEFs to
translocate and activate Rac1 at the plasma membrane as well as
bind the PH domain of Akt to mediate its translocation to the
plasma membrane. However, activation of Akt by phosphorylation
was not observed. Thus, Msp is able to act at the plasma
membrane to activate the PI3K pathway; however, individual
downstream components of this pathway are evidently affected
differently. How Msp acts at the plasma membrane of fibroblasts is
not currently known. However, it is unlikely that Msp penetrates
the plasma membrane [19]; Msp probably acts through activation
of cell signalling cascades upon extracellular contact with the
plasma membrane. For example, Msp has been demonstrated to
form pores in model lipid bilayers and HeLa cell membranes, as
well as to depolarize and induce acute calcium ion influxes across
plasma membranes [19,42,43].
Although Rac1 and PI3K are well established in the regulation
of actin dynamics, it appears that neither of these elements alone
are required for Msp-induced actin rearrangement. Neither
chemical inhibition of PI3K nor transfection with a Rac1DN
construct was able to prevent F-actin reorganization by Msp. Even
though studies have shown that expression of either active Rac1 or
PI3K alone are able to cause actin rearrangement in fibroblasts
[31,41], our results suggest that Msp impacts either multiple
Figure 6. Msp-mediated actin rearrangement and free barbed
end formation does not require PI3K activity. (A) Fibroblasts were
treated with or without the PI3K inhibitor LY294002 prior to Msp
exposure. Cells were partially permeabilized, followed by the addition
of rhodamine labelled actin monomers. Incorporation of labelled actin
monomers was determined by fluorescence intensity measurement
using Image J. Graph represents the mean intensity 6 SEM of 3
experiments (compared to control cells, **P,0.01). (B) Representative
Alexa-phalloidin stained images of total F-actin with and without
LY294002 treatment prior to Msp exposure. Bar represents 25 mm.
doi:10.1371/journal.pone.0023736.g006
Figure 7. A Treponema denticola Msp mutant partially prevents
stress fiber alteration. Rat-2 cells were treated with wildtype T.
denticola 35405 or the Msp mutant MHE for 30 min, followed by F-actin
labelling with Alexa-phalloidin. An average of 80 cells per group were
counted and the number of cells with altered stress fibres were
reported. Graph represents 3 independent experiments (mean 6 SEM,
** P,0.01).
doi:10.1371/journal.pone.0023736.g007
Figure 8. Msp increases cofilin phosphorylation. Cofilin activity
as measured by phosphorylation at serine 3 in Msp-treated cell lysates
was analyzed by immunoblotting. Densitometry analysis is shown in
panel A. Graph represents mean 6 SEM of 3 experiments. (*P,0.05). A
representative immunoblot is shown in panel B. EGF treated cell lysates
serves as a positive control for cofilin dephosphorylation.
doi:10.1371/journal.pone.0023736.g008
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dynamics.
Actin filament assembly, including FBE formation, is directly
regulated by both cytoskeleton binding effectors and local changes
in polyphosphoinositides such as PIP2 [29,44]. It is dependent
upon initial formation of FBEs and subsequent elongation of
filaments [45]. Previously, we reported that Msp-induced actin
FBE formation in both fibroblasts and neutrophils [15]. Here, we
demonstrate for the first time that cell exposure to Msp induces the
removal of the capping proteins gelsolin and CapZ from actin
barbed ends in fibroblasts. We propose that uncapping is the
primary mechanism of FBE formation caused by cell exposure to
Msp. PIP2 is known to induce dissociation of both gelsolin and
CapZ from actin termini in multiple cell types, including platelets
and fibroblasts [46,47,48]. Our experiments using the PLCd1-PH-
GFP probe to monitor PIP2 dynamics [49] together with an
ELISA based assay indicated that Msp increases cellular PIP2
levels and induces recruitment of PIP2 to local areas of actin
rearrangement at the plasma membrane. Using a cell-permeant
peptide PBP-10, which mimics the PIP2 binding site on gelsolin
[50], we showed that PIP2 is required for Msp-mediated actin
uncapping. Notably, inhibition of PIP2 binding using the gelsolin-
derived peptide, PBP-10, is also able to prevent removal of CapZ
from actin filaments. We propose that removal of capping proteins
by PIP2 is a key mechanism involved in Msp-mediated actin FBE
formation.
Changes in PIP2 levels can result from synthesis by
phosphoinositol phosphate kinases (PIPK) [51] or degradation
of PIP3 by phosphoinostide phosphatases (PP) [36]. Our studies
here, using soluble PIP3 as a substrate, showed that the amount
of free phosphate increased following Msp treatment, confirming
the involvement of a PP in Msp-mediated PIP2 production. As
PLC recognizes the (4,5) PIP2 form rather than the (3,4) PIP2
form [35], PIP3 is probably dephosphorylated at the 3-OH
following cell exposure to Msp. The 3- phosphoinositide
phosphatase PTEN (phosphatase and tensin homologue deleted
on chromosome 10) is able to dephosphorylate PIP3 to PIP2 [52]
and is a compelling candidate that may be involved in PIP2
production by Msp. Similarily, our data using a synthetic
bisperoxovanadate compound which is able to inhibit multiple
phosphatases, including PTEN [53], indicate that PIP2 is formed
by Msp through PTEN.
The actin binding protein cofilin has two functions in the cell, to
depolymerize actin filaments, resulting in monomer turnover, and
to sever filaments to create FBEs. Cofilin is normally inactive in
resting cells, inhibited either by binding to PIP2 or by
phosphorylation at serine 3 [54]. Our data indicate that cofilin
remains inactive due to phosphorylation, following Msp exposure.
Small GTPases, including RhoA are also able to activate kinases
responsible for cofilin phosphorylation [54], which may be at play
following Msp exposure, supported by our observed Msp-induced
activation of RhoA. Furthermore, Msp-mediated PIP2 production
may also be involved in concurrent cofilin inactivation. Therefore,
normal actin dynamics and subsequent cell movement are
probably impaired, as activation of cofilin is known to be among
the key regulators for protrusion of the cell’s leading edge [55,56].
The pathways by which T. denticola Msp induces actin filament
reorganization appear to be unique among bacterial factors that
Figure 9. Msp results in uncapping of actin free barbed ends. Fibroblasts were treated with Msp for the indicated times followed by partial
permeabilization. The amount of CapZ and gelsolin released from the cell was quantified using immunoblot. Densitometry analysis of released
protein is shown (mean 6 SEM of 3 independent experiments, *P,0.05, **P,0.01 compared to no treatment) for gelsolin (A) and CapZ (C).
Representative immunoblots are shown in panels B and D.
doi:10.1371/journal.pone.0023736.g009
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Little evidence exists that T. denticola invades host cells as a
significant feature of its pathogenicity [57]. Similarly, its Msp
does not appear to pass through the plasma membrane into the
cytosol ([19], M. A. Magalhaes, unpublished). Further we
demonstrate here that Msp in its native state in whole bacteria
does play a role in host cell cytoskeleton alteration, as a Msp
mutant had significantly diminished stress fiber perturbing
activity. The analysis of the T. denticola 35405 genome has not
found any deduced secretion systems which allow penetration of
host cell membranes and injection of bacterial proteins into the
cytosol (type III, IV or VI), although other general secretion
systems to the extracellular environment are present [58]. We
suggest that Msp perturbs the fibroblast actin cytoskeleton
through a signalling cascade that is novel among those so far
reported for bacterial pathogens (Figure 12). Rather than
invading or secreting effectors inside the cell to subvert the host
machinery, extracellular contact with Msp induces a fibroblast
phosphatase that enhances PIP2 production and recruitment,
leading to actin filament uncapping and subsequent de novo
subcortical actin assembly.
Methods
Treponema denticola Msp enrichment
Native Msp complex was enriched from broth cultures of T.
denticola ATCC 35405 as previously described [18,19] and
confirmed by coomassie staining and western blot to be highly
pure (data not shown). Msp was used at a concentration of 20 mg
ml
21 which has been previously determined to promote actin
reorganization in fibroblasts [15,18].
Fibroblast cell culture
Rat-2 fibroblasts (ATCC CRL 1764) were cultured in a-MEM
containing 10% heat- inactivated fetal bovine serum (FBS) and
100 U ml
21 penicillinG and 50 mgm l
21 gentamicin (Invitrogen).
Rat-2 cells from passages 4 through 15 were used for
experiments.
Treponema culture conditions and stress fiber assay
T. denticola 35405 and the Msp mutant MHE (gift of Christopher
Fenno, University of Michigan) were grown as described [59]. For
assays, Treponema strains were grown for 3 days anaerobically,
Figure 10. Msp induces PIP2 formation and recruitment to areas of actin remodelling. (A) Rat-2 fibroblasts were transfected with PLCd1-
PH-GFP prior to Msp treatment, fixation and labelling of total F-actin with Alexa-phalloidin and plasma membrane labelling with Alexa-WGA. Msp
exposure increased local recruitment of PLCd1-PH-GFP to actin-rich areas at the plasma membrane. Scale bar equals 25 mm. (B) Total lipids were
extracted following Msp treatment and the amount of cellular PIP2 was measured using an ELISA assay. Graph represents the mean 6 SEM of 4
experiments. (C) Phosphatase activity was measured using a malachite green assay. Soluble PIP3 substrate was added to supernatant samples from
partially permeabilized cells following Msp exposure. The amount of free phosphate released increased following Msp exposure. Graph represents
the mean 6 SEM of 3 experiments. (*P,0.05, **P,0.01, ***P,0.001).
doi:10.1371/journal.pone.0023736.g010
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(approx. 2610
9 cells / ml). Rat-2 cells were grown 18 hr on
coverslips in 24-well plates at 9610
4 cells / well. One ml of
bacterial suspension was added to Rat-2 cells followed by
incubation for 30 min 5% CO2. Rat-2 cells were washed, fixed
and F-actin labelled with Alexa-594 phalloidin. The percentage of
cells showing stress fiber reorganization was determined as
previously described [15,33].
Transfection of fibroblasts
To inhibit Rac1 activity, Rat-2 cells were transfected with a
Rac1 dominant negative-enhanced green fluorescent protein
(EGFP) fusion (Rac1-T17N). For localization of PIP2 in cells, we
used a PH-PLCd1-GFP fusion construct, while localization of
PIP3 was visualized with a PH-AKT-GFP fusion construct (all
plasmids were a gift of Sergio Grinstein, SickKids Hospital,
Toronto, Ontario). Rat-2 cells were grown in 8-well chamber
slides (Lab-Tek, Nunc; 2610
4 cells per well) for 24 h, followed by
transfection using FuGENE 6 (Roche). The cells were allowed to
recover for 24 h prior to treatment with Msp for 60 min in 5%
CO2 at 37uC. Following treatment, the cells were fixed with 4%
paraformaldehye, permeabilized with 0.1% Triton-X100, F-actin
labelled using Alexa-594 phalloidin and the plasma membrane
labelled with Alexa-647 wheat germ agglutinin (WGA) (Invitro-
gen).
Immunofluorescence
To study localization of small GTPases following Msp
treatment, 1610
4 Rat-2 cells were grown for 48 h in 8 well
chamber slides then serum starved for 4 h. Following Msp
treatment for 5 or 30 min, cells were fixed with 4% paraformal-
dehye, permeabilized with 0.1% Triton-X100, and blocked with
5% normal goat serum (NGS) for 30 min at room temperature.
Primary antibodies were diluted in 5% NGS and applied for 1 h at
Figure 11. PIP2 is required for Msp-mediated actin uncapping and FBE formation. Pretreatment of cells with the cell permeable
phosphoinositide binding peptide PBP-10 (A) or the PTEN phosphatase inhibitor bpV(pic) (B) prevented Msp-mediated release of both gelsolin and
CapZ from permeabilized cells. Graphs represent densitometry analysis of 2 experiments (mean 6 SEM, * P,0.05 compared to control cells, + P,0.05
compared to Msp treatment). (C) Pretreatment of cells with PBP-10 prevented incorporation of biotin-labelled actin monomers at actin FBE.
Representative images are shown.
doi:10.1371/journal.pone.0023736.g011
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secondary antibody (Invitrogen). Primary antibodies used were
Rac1 (Upstate Biotechnlogy), Cdc42 (BD biosciences) and RhoA
(Santa Cruz Biotechnology). F-actin was labelled with Alexa-488
phalloidin and nuclei were stained with 49,6-diamidino-2-pheny-
lindole (DAPI, Roche).
Small GTPase activation assays
To determine the activation state of Rac1, RhoA and Cdc42 by
Msp, G-LISA assays were used following the manufacturer’s
instructions (Cytoskeleton Inc). Briefly 2610
5 cells were grown in
100-mm dishes for 3 days, followed by serum starvation overnight.
Cells were treated with Msp for 5, 15, 30 or 60 min, washed and
lysed. Equal amounts of cell lysate samples were used in the G-
LISA assays. Rac1 and RhoA activation was measured using a
luminescence plate reader (FLUOstar Optima). Cdc42 activation
was determined by absorbance values (plate reader model 3550,
BioRad).
The Ras activation state following Msp treatment was
determined using a Raf-Ras-binding domain (RBD) bound to
glutathione agarose beads (Cytoskeleton Inc). 1610
5 cells were
grown in 150-mm dishes for 4 days, followed by overnight
serum starvation. Following Msp treatment as above, cells were
lysed and 400 mg of cell lysate was added to 35 mlR a f - R B D
beads and incubated for 1 h at 4uC. Bead samples were
collected, washed and analyzed by SDS-PAGE. Proteins were
transferred to nitrocellulose (Bio-Rad) overnight at 4C. Follow-
ing transfer, membranes were blocked for 30 min with 5%
milk/ TBS/ 0.05% Tween-20, incubated in pan anti-Ras
antibody for 3 h at room temperature followed by goat anti-
mouse peroxidase-conjugated secondary antibody (Cell signalling
Technology). Blots were developed using Western Lighting ECL
substrate (Perkin-Elmer) and imaged using a Chemidoc-XRS
detector (Bio-Rad). To serve as positive controls, cells were
treated for 10 min with 100 ng/ml epidermal growth factor
(EGF, Sigma) (Rac1, Cdc42 and Ras) or 10 mM lysopho-
sphatidic acid (LPA, Sigma) (RhoA).
To confirm Rac1 inhibition following Rac1 dominant negative
transfection, Rat-2 cells were treated with or without EGF
followed by pulldown assay using PAK-GST agarose beads as
described previously [16]. Active Rac1 was visualized by
immunoblotting as described above using a Rac1 primary
antibody (Upstate Biotechnology).
PI3K inhibition
To study the impact of PI3K inhibition, cells grown in 100-mm
dishes were treated with 100 mM LY294002 (Cell Signalling
Technology) or DMSO as vehicle control for 30 min at 37uCi n
5% CO2 prior to treatment with Msp or a-MEM for 15 min.
Following Msp treatment, lysates were prepared and Rac1 and
RhoA activation levels were measured using the appropriate G-
LISA as above (Cytoskeleton).
Actin Free Barbed End assay
The generation of actin FBEs was determined by incorporation
of rhodamine-labelled actin monomers as previously described,
with slight modifications [15]. Rat-2 cells were grown in 8-well
chamber slides followed by serum starvation for 4 h. In some
experiments, the PI3K inhibitor LY294002 was added for 1 h, the
rhodamine labelled peptide, PBP-10 for 10 min or vehicle
followed by Msp treatment for 30 min. Cells were simultaneously
permeablized and labelled with rhodamine muscle actin mono-
mers (Cyotskeleton Inc) by exposure for 30 s to 100 ml of 0.5 mM
rhodamine actin in OG buffer (0.4% n-octyl-b-glucopyranoside in
PHEM buffer (60 mM PIPES, 25 mM HEPES, 10 mM EGTA,
2 mM MgCl2, 0.1 mM ATP pH 6.9). Permeabilization was
stopped by adding 300 ml of buffer B (1 mM Tris, 1 mM EGTA,
2 mM MgCl2, 10 mM KCl, 5 mM ATP, 5 mM b-mercaptoeth-
anol pH 7.4) for 2 min at room temperature. Cells were washed,
fixed for 10 min and permeabilized with 0.1% triton for 5 min. F-
actin was labelled with Alexa-488 phalloidin for 20 min at room
temperature. Slides were mounted using Prolong Gold medium
(Invitrogen). FBE assays following PBP-10 treatment were
performed as above except cells were labelled with biotin muscle
actin monomers (Cytoskeleton) and Alexa-633 Streptavidin
(Invitrogen) was used to visualize FBEs. Fluorescence intensity
was measured using ImageJ.
Image acquisition
Cells were examined by epifluorescence microscopy (Leica
DMIRE2) and images obtained using OpenLab software (Perkin
Elmer) or by spinning disk confocal microscopy (Leica DMIRE2
Figure 12. A model for the action of Msp in subcortical actin filament assembly in fibroblasts. Msp treatment of fibroblasts results in
activation of both PI3K and a host 3-phosphoinositide phosphatase, resulting in turnover of PIP3 to PIP2. PIP2 then causes removal of actin capping
proteins, FBE formation and dependent actin filament assembly, even though cofilin remains inactive. Although Msp activates Rac1, RhoA and Ras,
our data suggest that these small GTPases are not directly involved in Msp-induced subcortical actin assembly. ; indicates pathway activated, \
indicates pathway inhibited.
doi:10.1371/journal.pone.0023736.g012
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using Volocity software (Perkin Elmer).
Actin binding protein quantification
The phosphorylation state of the actin binding protein cofilin
was determined following Msp treatment. Cells were grown and
treated as described above. Equal amounts of cell lysates were
analyzed for phospho-cofilin (Serine 3, Cell Signalling Technol-
ogy) levels by western blotting followed by HRP inactivation and
reprobing with a total cofilin antibody (Cell Signalling Technol-
ogy). As a positive control, cell lysates were used from Rat-2 cells
treated with 100 ng/ml EGF for 5 min.
The amount of gelsolin and CapZ present in the supernatant of
partially permeabilized cells and total cell lysate was also
determined. Confluent fibroblasts in 100-mm dishes were treated
with Msp for 5 or 30 min, washed and permeabilized with 400 ml
of 0.4% OG buffer for 30 s. The supernatant was collected and
concentrated using amicon devices (10,000 MWCO, Millipore)
and separated by SDS-PAGE. The cells were scraped from the
plate, lysed by passage through a 21 gauge needle, and
resuspended in SDS sample buffer followed by SDS-PAGE.
Following transfer to a nitrocellulose membrane, samples were
blotted with anti-gelsolin (gift of Christopher McCulloch, Univer-
sity of Toronto) or anti-CapZ antibodies (BD biosciences). In some
experiments, cells were treated with 30 mM polyphosphoinsoitide-
binding peptide PBP-10 [50] (Calbiochem) for 10 min or 100 nM
PTEN inhibitor bpV(pic) [53] (Santa Cruz) for 30 min prior to
Msp treatment.
Akt analysis
Rat-2 fibroblasts were grown in 60-mm, 100-mm dishes or 8-
well chamber slides as above and treated with Msp. For western
blot analysis, equal amount of total protein lysates were separated
by SDS-PAGE, followed by transfer to PVDF. Membranes were
blocked in 5% milk/ TBS/ 0.1% Tween-20, incubated overnight
in primary antibody (anti-Akt Serine 473, Cell Signalling
Technology) followed by secondary antibody. Following develop-
ment, HRP was inactivated with 0.2% sodium azide and reprobed
with an anti-non-phosphorylated Akt antibody (Cell Signalling
Technology). Crude membrane and cytosol fractions were
prepared as follows. Cells were scraped from the dish with cold
cytosol buffer (20 mM Tris, 150 mM NaCl, pH 7.5, protease
inhibitor cocktail (Sigma)), followed by 3 cycles of freezing in liquid
nitrogen and thawing at 37uC. Samples were centrifuged and the
supernatant represented the cytosol fraction. The pellet was
washed in cytosol buffer, centrifuged and suspended in membrane
buffer (cytosol buffer containing 1% Triton X-100). Following
centrifugation, the supernatant represented the membrane
fraction. Samples were analyzed by immunoblotting as above.
Phosphatase activity assay
The amount of free phosphate was determined using a modified
malachite green phsophatase assay. 1610
5 cells were grown per
well in 12-well plates (Corning) for 24 h following by serum
starvation overnight. Cells were treated with Msp prepared in
phosphate-free HBSS, followed by permeabilization with 0.1
volume of 2% OG for 15 s. Sixty ml of solution was removed, to
which 1 mM of Phosphatidylinositol 3,4,5-trisphosphate diC8
(Echelon) was added as a substrate. Twenty five ml of this mixture
was incubated with 100 ml of malachite green solution (Echelon) in
a 96 well plate for 10 min. Absorbance at 650 nm was measured
using a microplate reader (VERSAmax plate reader, Molecular
Devices Corporation) and the amount of free phosphate calculated
using a prepared phosphate standard curve.
PIP2 assay
PI(4,5)P2 levels were measured in cell extracts using a
competitive binding ELISA (Echelon). 3610
5 cells were grown
per well in 6-well plates overnight followed by serum starvation.
Cells were treated with Msp in a timecourse, followed by lipid
extraction according to the manufacturer’s protocol. Dried
samples were resuspended by sonication and assayed in duplicate.
Statistical analysis
Comparisons between two groups were performed using t-tests.
Multiple sample comparisons were performed using one-way
ANOVA, with a Dunnett multiple comparison test. Results are
based on at least 3 independent experiments. Statistical signifi-
cance was defined as P,0.05. For colocalization studies, Pearson
coefficient analysis of dual-labelled images of the same cells was
performed using ImageJ.
Supporting Information
Figure S1 Localization of Akt-PH-GFP following Msp
treatment. Rat-2 fibroblasts were transfected with Akt-PH-GFP
prior to Msp treatment and fixation. Representative images are
shown in panel A. (B) Fluorescence intensity at the plasma
membrane was quantified using ImageJ. PDGF treatment serves
as a positive control for recruitment to the plasma membrane.
Graph represents mean 6 SEM of 3 experiments (P,0.05).
(TIF)
Figure S2 Treatment of fibroblasts with a PIP2 binding
peptide or a lipid phosphatase inhibitor prevents Msp-
mediated actin uncapping. Rat-2 cells were pretreated with
(A, C) PBP-10 or (B, D) bpV(pic) prior to Msp treatment.
Representative immunoblots of the amount of released gelsolin
(A, B) and CapZ (C,D) are shown.
(TIF)
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